Sleep Apnea, Central Completed Phase 4 Trials for Naltrexone (DB00704)

Also known as: Central Sleep Apnea / Sleep Apnea Central / Central sleep apnoea syndrome / Central sleep apnea syndrome (disorder) / Central sleep apnea syndrome

IndicationStatusPhase
DBCOND0003369 (Sleep Apnea, Central)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05037032Effects of Naltrexone on Nocturnal Breathing Patterns at AltitudeSupportive Care